Sunil Cherry

Sunil Cherry practices at Neurodiagnostic Center PA in Lufkin, Texas.

Sunil Cherry's NPI, 1659559763, was assigned on January 31, 2008. Sunil Cherry graduated from Texas Tech University Health Sciences Center School of Medicine in 2006. Sunil Cherry holds Texas license P0023.

Sunil Cherry's primary practice is Neurodiagnostic Center PA, at 302 Medical Park Dr, Lufkin, TX 75904 in Angelina County. The practice phone is (936) 634-6333.

Sunil Cherry's primary practice is Neurodiagnostic Center PA in Lufkin, Texas. Sunil Cherry is also affiliated with St. Luke's Health - Memorial Hospital - Lufkin, TX. The medical group on file is Austin State Hospital. Dmand AI also links Sunil Cherry to 4 more hospitals, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sunil Cherry practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Sunil Cherry's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Sunil Cherry is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Sunil Cherry's licenses on file in 2 states: Texas and Georgia.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Sunil Cherry treats.

CMS data shows 2,930 Medicare services from Sunil Cherry across 15 procedure codes in 2024, for 1,151 Medicare patients. Medicare paid $313,104 for them.

CMS counts 1,151 Medicare patients who saw Sunil Cherry in 2024. The largest group is 75 to 84, with 426 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sunil Cherry's median patient age at 73, with 59% women.

In 2024, Sunil Cherry wrote 8,596 Medicare Part D claims for 1,239 patients. 89% of them were for generic drugs. CMS names the drug for 8,374 of them, across 79 drugs with 11 or more claims each, at $2,133,759 in total drug cost. In 2023, CMS named 8,601 claims across 84 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Sunil Cherry for performance year 2024, reported individually. Sunil Cherry accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sunil Cherry as offering telehealth.

Dmand AI links 5 papers to Sunil Cherry, published from 2007 to 2011. Sunil Cherry has published most often in Nat Med. Sunil Cherry's most frequent co-authors are Hoda K. Elzawahry, MD, Arthur I. Jacobson, MD and Lilith Marion Judd, MD.

CMS Open Payments shows 802 general payments to Sunil Cherry from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Sunovion Pharmaceuticals Inc. paid the most, $1,497.

Sunil Cherry graduated from Texas Tech University Health Sciences Center School of Medicine in 2006. Sunil Cherry is a member of AAN.

Sunil Cherry is in network with 20 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.